Skip to main content
. 2010 Dec;163(6):919–924. doi: 10.1530/EJE-10-0764

Table 1.

In vivo low dose drug cocktail phenotyping for assessment of drug-metabolizing cytochrome P450 (CYP) enzymes including selective substrates employed, respective doses and phenotyping parameters.

Drug-metabolizing CYP enzymes Drug Dose (mg) Phenotyping parameter (unit)
CYP1A2 Caffeine 150 Oral caffeine clearance (ml/min per kg body weight)
CYP2C9 Tolbutamide 125 Plasma concentration of tolbutamide 24 h post dose (μg/ml)
CYP2C19 Omeprazole 20 Ratio of the molar plasma concentrations of omeprazole over 5-hydroxyomeprazole 3 h post dose (−)
CYP2D6 Dextromethorphan hydrobromide 30 Ratio of the molar plasma concentrations of dextromethorphan over dextrorphan 3 h post dose (−)
CYP3A4 Midazolam 2 Oral midazolam clearance (L/hl)